Statistics for BO-264: Highly potent TACC3 inhibitor as a novel anticancer drug candidate
Total visits
views | |
---|---|
BO-264: Highly potent TACC3 inhibitor as a novel anticancer drug candidate | 21 |
Total visits per month
views | |
---|---|
January 2024 | 2 |
February 2024 | 2 |
March 2024 | 0 |
April 2024 | 6 |
May 2024 | 4 |
June 2024 | 0 |
July 2024 | 0 |
File Visits
views | |
---|---|
Ozge Akbulut_MBG_MFBE_January 2021.pdf | 68 |
Top country views
views | |
---|---|
Turkey | 12 |
United Kingdom | 2 |
India | 2 |
China | 1 |
Hong Kong SAR China | 1 |
Top city views
views | |
---|---|
Istanbul | 8 |
Kastamonu | 2 |
Ankara | 1 |
Bergama | 1 |
Blackheath | 1 |
London | 1 |
Panjim | 1 |
Shanghai | 1 |